COMPASS BIOTECHNOLOGIES, INC. Inactive Instrument
Compass Biotechnologies, Inc. Share Price Other OTC
Equities
US20452Q1031
Pharmaceuticals
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2018 | - | Sales 2019 | - | Capitalization | 2L 1.32Cr |
|---|---|---|---|---|---|
| Net income 2018 | - 0 | Net income 2019 | - 0 | EV / Sales 2018 | - |
| Net Debt 2018 | 5L 4.31Cr | Net Debt 2019 | 5L 4.01Cr | EV / Sales 2019 | - |
| P/E ratio 2018 |
-2.59
x | P/E ratio 2019 |
-3.95
x | Employees | - |
| Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 99% |
More Fundamentals
* Assessed data
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Nicole Birch
CEO | Chief Executive Officer | - | 18/20/18 |
Mathew Knowles
SAM | Sales & Marketing | - | 22/19/22 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Nicole Birch
CEO | Chief Executive Officer | - | 18/20/18 |
Bangi Inc. is focused on the acquisition, ownership and management of properties leased to experienced, state-licensed operators for regulated use of Cannabis facilities. The Company intends to acquire properties through sale-leaseback transactions and third-party purchases.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| +43.17% | 615.77Cr | |
| -14.69% | 446.26Cr | |
| -8.17% | 326.89Cr | |
| +6.95% | 319.78Cr | |
| -1.76% | 259.92Cr | |
| +50.20% | 197.54Cr | |
| -7.85% | 169.77Cr | |
| -0.40% | 166.12Cr | |
| -9.91% | 160.9Cr |
